Rankings
▼
Calendar
VERA Q2 2024 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VERA
Vera Therapeutics, Inc.
$3B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$37M
Net Income
-$34M
EPS (Diluted)
$-0.62
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$397M
Total Liabilities
$69M
Stockholders' Equity
$328M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$37M
-$22M
-70.0%
Net Income
-$34M
-$20M
-67.2%
← FY 2024
All Quarters
Q3 2024 →